Since consistent CLIC4 structural genomic alterations were not detected in human cancers in our previous study [27], we reasoned that elevated CLIC4 in progressive breast cancer was likely related to TGF-β pathway expression, a major regulator of CLIC4 expression [21] and an important influence on breast cancer outcome [28]. The gene discussed is CLIC4; the disease is cancer.